Stocks to Watch, March 24: Google, Bayer

...ba href=/hyperactivity/a/b disorder in children and adolescents.

Cephalon said the committee decided that Sparlon is effective for its intended use but recommended that the company collect additional data to support the safety of the drug.

As a result, Cephalon lowered its 2006 sales forecast by $100 million to a range of $1.45 billion to $1.5 billion.

German drugmaker Bayer AG (BAY) plans to outbid rival Merck KGaA (MKGAF) for Schering AG (SHR) .

See full story.

Electroglas Inc.

(EGLS) said the third-quarter net loss was $4.22 million, or 19 cents a share, compared with a net loss of $8.79 million, or 40 cents a share, during the same period last year.

The provider of semiconductor capital equipment said quarterly revenue was $11.3 million, up from $8.43 million last year.

Analysts polled by Thomson First Call had expected revenue of $11 million.

The Finish Line Inc.

(FINL) said fourth-quarter net income was $28.1 million, or 58 cents a share, compared with $28.2 million, or 57 cents a share, reported a year ago.

The athletic wear retailer said sales rose 10% to $399.2 million from last year's $361.4 million.

Excluding one-time charges, the company's earnings would have been 63 cents a share.

Analysts polled by Thomson First Call expected, on average, earnings of 59 cents a share.

Legg Mason Inc.

(LM) named James W.

Hirschmann as president of the company effective May 1, taking the role held by Raymond "Chip" Mason who will continue as chairman and chief executive.

See full story.

Palm I...

Use of Drug to Treat ADHD in Children Opposed

...ba href=/hyperactivity/a/b disorder in children until more is learned about a possible link to a serious skin disease, federal advisers said yesterday.A Food and Drug Administration advisory committee voted 12 to 1 against recommending modafinil as safe for children with ADHD.

Earlier, the psychopharmacologic drugs panel unanimously agreed that modafinil works as a treatment for ADHD.

Well, Well, Well And the perfect kids' beverage is...Mind the agenda...A legal nightmare...Now that's depressing...

Well, Well, Well: A Log of Notes and Observations #delicious_display { display:none ; color:#333333 ; background-color:#EEEEEE ; padding:4px ; padding-top:0px ; border:1px dotted #0D3159 ; } Save & ShareTag This Article Saving options1.

Save to description: Headline (required)2.

Save to notes (255 character max): Blurb3.

Tag This Article The FDA is not required to follow the recommendations of its advisory panels but usually does.The committee recommended that Cephalon Inc.

undertake a 3,000-patient trial to determine the risk modafinil may pose for Stevens-Johnson syndrome.

Drug reactions cause nearly all cases of the sometimes fatal skin disease, which can produce widespread blistering and rashes, according to the Merck Manual.The FDA's drug evaluation chief, Robert J.

Temple, said one out of 900 children involved in earlier studies of the drug developed the disease.

He and Cephalon spokeswoman Jenifer Antonacci said the agency and the company will discuss the committee's recommendation.In De...

FDA recommends against treating ADHD with modafinil

...ba href=/hyperactivity/a/b disorder (ADHD) in children and teenagers.

The psychopharmacologic drugs panel voted 12-1 against the recommendation.

It concluded that the drug is effective against ADHD, but can't be regarded as safe for the use by children for the time being, reports reaching here said.

The panel was most concerned about a possible link with skin rashes and recommended that the drug's manufacturer, Cephalon Inc., conduct a 3,000-patient trial to measure the risk.

The drug is also found in link with psychiatric effects including mania and aggression.

Modafinil is being marketed as Provigil for treating sleep disorders.

Cephalon is seeking to sell the drug under the name Sparlon for children with ADHD.

Enditem Editor: Zhu Jin Related Story Sharon Stone attends premieres of "Basic Instinct 2" Sonia resigns as MP, to fight election again Ding moves to top 16 of World Snooker China Open - China says no to Japan's proposal on UN dues - Lukashenko confirmed as winner in Belarus vote - US: No final deal reached over Iran's nuclear issue - Sonia resigns as MP, to fight election again - Shanghai reports one suspected human bird flu death case ...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news